XBiotech Inc. (NASDAQ:XBIT – Get Free Report) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $6.63 and traded as high as $7.93. XBiotech shares last traded at $6.79, with a volume of 289,689 shares traded.
XBiotech Trading Down 14.6 %
The company has a market cap of $206.81 million, a PE ratio of -6.66 and a beta of 1.41. The firm has a 50 day moving average of $6.63 and a two-hundred day moving average of $7.11.
XBiotech (NASDAQ:XBIT – Get Free Report) last released its earnings results on Monday, August 12th. The biopharmaceutical company reported ($0.43) EPS for the quarter.
Institutional Trading of XBiotech
XBiotech Company Profile
XBiotech Inc, a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation.
See Also
- Five stocks we like better than XBiotech
- Basic Materials Stocks Investing
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Investing in Construction Stocks
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Best Stocks Under $5.00
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for XBiotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XBiotech and related companies with MarketBeat.com's FREE daily email newsletter.